Is your organization missing from this list? Reach out to Danielle Cann, Strategic Alliance Partnership Coordinator, to learn more about the complimentary strategic partnership program: dcann@mjhlifesciences.com
Cabozantinib Combo Maintains PFS for Advanced RCC at Follow-Up
Nivolumab Plus Cabozantinib Effective Long-Term for Advanced RCC
High PSA Levels Before HIFU May Increase Recurrence Risk in Intermediate-Risk Prostate Cancer
Enfortumab Vedotin and Pembrolizumab Effective in Treating Primary UTUC Lesions